1.
La sitagliptine dans le traitement du diabete de type 2: le point, cinq ans apres sa commercialisation. ; Sitagliptin in the treatment of type 2 diabetes: insights five years after...
2.
Le medicament du mois. Rosuvastatine (Crestor). ; Drug of the month. Rosuvastatin (Crestor)
Le medicament du mois. Bydureon: premier agoniste des recepteurs du GLP-1 en une injection hebdomadaire (exenatide a liberation prolongee). ; Bydureon: first once weekly GLP-1 rece...
Urinary Levels of Bisphenol A, Triclosan and 4-Nonylphenol in a General Belgian Population
3.
4.
5.
6.
7.
8.
9.
Is the contamination of the Belgian population by endocrine disruptors linked to thyroid disorders ?
2C-B draws attention on the Belgian market: description of the first of the 2Cs
2C-B Draws Attention on the Belgian Market - Description of an Amphetamine derivative
Association between endocrine disruptor contamination and thyroid hormone homeostasis in Belgian type 1 diabetic children.
From point prevalence surveys to continuous quality improvement in a teaching hospital in Belgium
Meet the needs of elderly at primary care : Experience from Belgium